Luminary Therapeutics

About:

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.

Website: http://luminarytx.com/

Top Investors: ScaleReady

Description:

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases. It creates an engine that completes novel and early therapeutic discovery through Phase I clinical trial completion, enabling doctors to eliminate viral-based cell therapy issues. The company was founded in 2019 and is based in Minneapolis, Minnesota.

Total Funding Amount:

$2.99M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2019-01-01

Contact Email:

j.liter(AT)luminarytx.com

Founders:

Beau Webber, Branden S. Moriarity, David Largaespada, Jeff S. Liter

Number of Employees:

1-10

Last Funding Date:

2024-10-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai